HYSTERECTOMY: ETIOLOGY MAIN INDICATIONS AND CAUSATIVE FACTORS AND EPIDEMIOLOGY

Mualliflar

  • Ulug‘bek Axmedov Assistant, Department of Fundamental Medical Sciences, Termez University of Economics and Service ##default.groups.name.author##
  • Shahlo Qo‘yliyeva Student General Medicine, Tashkent Medical University, Termez Branch ##default.groups.name.author##
  • Maya Abdumalikova Student General Medicine, Faculty of Medicine, Termez University of Economics and Service ##default.groups.name.author##

##semicolon##

hysterectomy##common.commaListSeparator## etiology##common.commaListSeparator## epidemiology##common.commaListSeparator## uterine fibroids##common.commaListSeparator## abnormal uterine bleeding

Abstrak

Hysterectomy (surgical removal of the uterus) is among the most common major gynecologic procedures, performed for benign indications (uterine leiomyomas, abnormal uterine bleeding, adenomyosis, endometriosis, pelvic organ prolapse), premalignant lesions, malignancies, and-rarely-life-threatening obstetric emergencies (emergency peripartum hysterectomy). This review summarizes key etiologic drivers and risk factors, and synthesizes epidemiologic patterns, including population prevalence, regional and socio-demographic disparities, time trends, and the increasing uptake of minimally invasive hysterectomy. In the United States, the crude prevalence of hysterectomy among women aged ≥18 years was estimated at ~17.2% in 2021, with variations by education, income, disability status, and region.

##submission.citations##

1. Ziyayeva, M.F., et al. Gynecology: Textbook (2nd ed.). Tashkent: “O‘qituvchi”, 2008.

2. Ismatova, M.I. (Ed.). Nursing in Gynecology: Study Guide. Tashkent, 2018.

3. Boboqulov, L.S., Azimov, M.M., & Bahriddinov, F.M. Advantages of total hysterectomy compared with subtotal hysterectomy. Journal of Biomedicine and Practice, 2022, No. 3, pp. 78–84.

4. Shavkatov, T.M., Atoyev, B.S., Butaev, S.K., & Akbarov, N.I. Comparative analysis of surgical methods for correcting genital prolapse. Doktor Axborotnomasi, 2022, No. 2.2, pp. 98–102.

5. Bozorboyeva, X.M. Uterine fibroids: etiology, pathogenesis, clinical course, and treatment methods. Journal of Scientific Innovations and Intellectual Research, 2025, Vol. 1, No. 1, pp. 239–241.

6. globalscholars.uz

7. Negmadzhanov, B.B., Xalilova, N.X., Xalilov, N.R., Abdurakhmonov, M.Z., Kuvvatova, N.B., & Valiyeva, N.N. Placenta previa and placenta accreta in scarred uterus. Journal of Reproductive Health and Uro-Nephrology Research, 2023, Vol. 4, No. 1, pp. 73–75.

8. Ministry of Health of the Republic of Uzbekistan; Republican Specialized Scientific-Practical Medical Center of Oncology and Radiology. National clinical protocols for the “Cervical Cancer” nosology (Appendix to MoH Order No. 401 dated 25 December 2024). Tashkent, 2024.

9. Bulletin of the Tashkent Medical Academy (Vestnik TMA). Special issue: “Achievements and Development Prospects in Improving the Quality of Higher Medical Education.” Tashkent, 2024.

10. Murodova, Shohsanam. Restoring reproductive function in women with endometriosis. Bulletin of the Tashkent Medical Academy (Special Issue), 2024, p. 61.

11. Karimova, A.M., et al. Teaching and Methodological Complex for Obstetrics and Gynecology (for 4th-year students). Bukhara, 2018

##submission.downloads##

Nashr qilingan

2026-02-09